HemoShear: Drug Developer HemoShear Therapeutics Secures $3.5 Million Debt
HemoShear Therapeutics has secured $3.5 million in debt from undisclosed investors, according to a listing on Crunchbase. The Charlottesville, Va.-based... Read More The post Drug Developer HemoShear Therapeutics Secures $3.5 Million Debt appeared first on citybiz.
Read full article »
HemoShear is a Virginia-based biotechnology company that researches and develops novel therapeutics for the treatment of liver and metabolic disorders.
Read more